Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Both these drugs are used for the management of PDS type of FD”In the company’s words, NCT07174297 on ClinicalTrials.gov
- Tested for
- Postprandial Distress Syndrome
- Main trialPhase 3
- “The goal of this study is to "To compare the efficacy and safety of Acotiamide versus Itopride in patient with post prandial distress syndrome type of functional dyspepsia"”In the company’s words, NCT07174297 on ClinicalTrials.gov
- Other names
- Itopride
Coming up1
- 30 DecPhase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | 30 Dec 2026 | Acotiamide vs Itopride in Postprandial Distress Syndrome |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026